Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized Trial.
Action Potentials
/ drug effects
Adolescent
Adult
Blood Pressure
/ drug effects
Caffeine
/ administration & dosage
California
Central Nervous System Stimulants
/ administration & dosage
Cross-Over Studies
Double-Blind Method
Electrocardiography
Energy Drinks
/ adverse effects
Female
Healthy Volunteers
Heart Conduction System
/ drug effects
Heart Rate
/ drug effects
Humans
Male
Predictive Value of Tests
Time Factors
Young Adult
QT interval electocardiography
blood pressure
electrocardiography
energy drinks
hemodynamics
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
04 06 2019
04 06 2019
Historique:
entrez:
30
5
2019
pubmed:
30
5
2019
medline:
1
9
2020
Statut:
ppublish
Résumé
Background Energy drinks have been linked to an increase in emergency room visits and deaths. We aim to determine the impact of energy drinks on electrocardiographic and hemodynamic parameters in young healthy volunteers. Methods and Results A randomized, double-masked, placebo-controlled, crossover study was conducted in healthy volunteers. Participants consumed 32 oz of either energy drink A, energy drink B, or placebo within 60 minutes on 3 study days with a 6-day washout period in between. The primary end point of QT c interval and secondary end points of QT interval, PR interval, QRS duration, heart rate, and brachial and central blood pressures were measured at baseline, and every 30 minutes for 240 minutes. A repeated-measures 2-way analysis of variance was performed with the main effects of intervention, time, and an interaction of intervention and time. Thirty-four participants were included (age 22.1±3.0 years). The interaction term of intervention and time was statistically significant for Bazett's corrected QT interval, Fridericia's corrected QT interval, QT , PR , QRS duration, heart rate, systolic blood pressure, diastolic blood pressure, central systolic blood pressure, and central diastolic blood pressure (all P<0.001). The maximum change from baseline in Bazett's corrected QT interval for drinks A, B, and placebo were +17.9±13.9, +19.6±15.8, and +11.9±11.1 ms, respectively ( P=0.005 for ANOVA ) ( P=0.04 and <0.01, respectively compared with placebo). Peripheral and central systolic and diastolic blood pressure were statistically significantly different compared with placebo (all P<0.001). Conclusion Energy drinks significantly prolong the QT c interval and raise blood pressure. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT03196908.
Identifiants
pubmed: 31137991
doi: 10.1161/JAHA.118.011318
pmc: PMC6585360
doi:
Substances chimiques
Central Nervous System Stimulants
0
Caffeine
3G6A5W338E
Banques de données
ClinicalTrials.gov
['NCT03196908']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e011318Commentaires et corrections
Type : CommentIn
Références
Am J Cardiol. 2014 Jan 1;113(1):168-72
pubmed: 24176062
JAMA. 2003 Apr 23-30;289(16):2120-7
pubmed: 12709470
Int J Cardiol. 2016 Sep 1;218:318-323
pubmed: 27240158
Hypertension. 2016 Mar;67(3):541-9
pubmed: 26781281
Eur J Nutr. 2017 Sep;56(6):2081-2091
pubmed: 27312565
Eur J Nutr. 2014 Oct;53(7):1561-71
pubmed: 24474552
Addict Behav. 2014 Jan;39(1):253-8
pubmed: 24161375
Nutr Rev. 2014 Oct;72 Suppl 1:9-13
pubmed: 25293539
JAMA. 2004 Jan 14;291(2):216-21
pubmed: 14722148
Am J Med. 2010 Feb;123(2):184-7
pubmed: 20103032
Clin Physiol Funct Imaging. 2017 Nov;37(6):675-681
pubmed: 26931509
Prev Med Rep. 2016 Nov 14;5:65-70
pubmed: 27920973
Am J Emerg Med. 2016 Jul;34(7):1205-9
pubmed: 27162113
JAMA. 2013 Jan 16;309(3):297
pubmed: 23330173
Int J Cardiol. 2015 Jan 20;179:66-7
pubmed: 25464415
Med J Aust. 2009 Jan 5;190(1):41-3
pubmed: 19120009
J Am Heart Assoc. 2017 Apr 26;6(5):
pubmed: 28446495
Case Rep Cardiol. 2017;2017:4061205
pubmed: 28203465
Cleve Clin J Med. 2016 Dec;83(12):895-904
pubmed: 27938518
Acta Pharmacol Sin. 2018 Mar;39(3):382-392
pubmed: 29072257
Int J Cardiol. 2012 Jul 26;158(3):e51-2
pubmed: 22056042
Int J Cardiol. 2017 Mar 15;231:150-154
pubmed: 28189188
MMWR Morb Mortal Wkly Rep. 2012 Nov 9;61(44):895-8
pubmed: 23134972
Mayo Clin Proc. 2010 Nov;85(11):1033-41
pubmed: 21037046
J Am Heart Assoc. 2019 Jun 4;8(11):e011318
pubmed: 31137991
Curr Med Res Opin. 2013 Dec;29(12):1719-26
pubmed: 24020938
JAMA. 2015 Nov 17;314(19):2079-82
pubmed: 26547226
Br J Sports Med. 2009 Sep;43(9):657-62
pubmed: 19734499
Eur Heart J. 2014 Jul;35(26):1719-25
pubmed: 24459197
J Am Heart Assoc. 2016 Jun 17;5(6):
pubmed: 27317349
Case Rep Emerg Med. 2015;2015:537689
pubmed: 25767726
Fed Regist. 2005 Oct 20;70(202):61134-5
pubmed: 16237860
Ann Pharmacother. 2016 Oct;50(10):808-15
pubmed: 27340146
JAMA. 1993 Mar 24-31;269(12):1532-6
pubmed: 8445816
Cardiovasc Toxicol. 2012 Jun;12(2):175-9
pubmed: 22231478
Amino Acids. 2014 May;46(5):1147-57
pubmed: 24615238
BMJ Case Rep. 2011 Jun 29;2011:
pubmed: 22693185
Pharmacotherapy. 2001 Apr;21(4):437-42
pubmed: 11310517
Turk Kardiyol Dern Ars. 2013 Dec;41(8):738-42
pubmed: 24351951
J Electrocardiol. 1988 Aug;21(3):219-29
pubmed: 3171455